NO-independent regulatory site on soluble guanylate cyclase

Nature

Volumn 410, Issue 6825, 2001, Pages 212-215

  Stasch, Johannes Peter ^a   Becker, Eva Maria ^a   Alonso Alija, Cristina ^a   Apeler, Heiner ^a   Dembowsky, Klaus ^a   Feurer, Achim ^a   Gerzer, Rupert ^b   Minuth, Torsten ^a   Perzborn, Elisabeth ^a   Pleiß, Ulrich ^a   Schröder, Henning ^c   Schroeder, Werner ^a   Stahl, Elke ^a   Steinke, Wolfram ^a   Straub, Alexander ^a   Schramm, Matthias ^a  

^a BAYER AG   (Germany)

^b GERMAN AEROSPACE CENTER DLR   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 2 (N,N DIMETHYLAMINO)DIAZENDATE 2 OXIDE; 2 PHENYL 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 3 AZIDO N [5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL] 4 PYRIDINYL]BENZAMIDE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; BAY 51 9491; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYHEMOGLOBIN; PYRIDINE DERIVATIVE; RECOMBINANT ENZYME; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME REGULATION; FEMALE; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SPONTANEOUSLY HYPERTENSIVE RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BINDING SITES; BLOOD PRESSURE; CYCLIC N-OXIDES; CYSTEINE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; GUANYLATE CYCLASE; HEME; HUMANS; IMIDAZOLES; INDAZOLES; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PHOTOAFFINITY LABELS; PLATELET AGGREGATION INHIBITORS; PYRAZOLES; PYRIDINES; RATS; SOLUBILITY;

ANIMALIA; MAMMALIA;

EID: 0035826261     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35065611     Document Type: Article

References (28)

1. Nitric oxide: Physiology, pathophysiology, and pharmacology
2. Endothelium-derived relaxing factor: Discovery, early studies, and identification as nitric oxide (Nobel lecture)
3. Discovery of some of the biological effects of nitric oxide and its role in cell signaling (Nobel lecture)
4. Nitric oxide: A unique endogenous signaling molecule in vascular biology (Nobel lecture)
5. Substituted pyrazole derivatives
6. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
7. Characterization of 1H[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase
8. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery
9. Sensitizing soluble guanylate cyclase to become a highly CO-sensitive enzyme
10. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: Stimulation by YC-1, NO and CO
11. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung
12. Human soluble guanylate cyclase: Functional expression and revised isoenzyme family
13. Different effects of ANP and nitroprusside on cyclic GMP extrusion of isolated aorta
14. The vasodilator-stimulated phosphoprotein (VASP): Target of YC-1 and nitric oxide effects in human and rat platelets
15. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators
16. YC-1, a novel activator of platelet guanylate cyclase
17. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase
18. Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line
19. Mechanism of YC-1 induced activation of soluble guanylyl cyclase
20. Soluble guanylate cyclase: The forgotten sibling
21. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity
22. Transgenic rats with an additional renin gene (TGR(mRen2)27) as a sensitive model for the renal effects of NO synthase inhibition
23. Identification of histidine 105 in the β1 subunit of soluble guanylate cyclase as the heme proximal ligand
24. Localization of the heme binding region in soluble guanylate cyclase
25. Kinetics and equilibria of soluble guanylate cyclase ligation by CO: Effect of YC-1
26. The aggregation of blood platelets
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. Vasodilation and first experience with quantitative studies in whole-body autoradiography during drug development